Национальный Медицинский Университет Им. А.А. Богомольца
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Медицинский Университет Им. А.А. БогомольцаfiledCriticalНациональный Медицинский Университет Им. А.А. Богомольца
Priority to UAU200911506UpriorityCriticalpatent/UA47980U/en
Publication of UA47980UpublicationCriticalpatent/UA47980U/en
Investigating Or Analysing Biological Materials
(AREA)
Abstract
A method for assessing the treatment efficacy in the patients with the ischemic heart disease with stenocardia and arterial hypertension relates to the medicine, namely to the cardiology and may be used for the objective assessment of the antianginal effect of Celiprolol in the patients with the ischemic heart disease with stenocardia and arterial hypertension.
UAU200911506U2009-11-122009-11-12Method for assessing treatment efficacy in patients with ischemic heart disease with stenocardia and arterial hypertension
UA47980U
(en)
Method for assessing treatment efficacy of isosorbid dinitrate in patients with ischemic heart disease suffering from angina pectoris and arterial hypertension
Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
Method for assessing treatment efficacy of trandolopril in patients with ischemic heart disease suffering from angina pectoris and arterial hypertension
Method for assessing efficacy of s-metoprolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
Method of assessment of the effectiveness of treatment s-metoprolol patients with coronary heart disease with angina and hypertension in violation of left ventricular diastolic function in "hypertrophic" type
Method of assessment of the effectiveness of treatment s-amplodypinom patients with coronary heart disease with angina and hypertension in violation of left ventricular diastolic function in "hypertrophic" type
Method for assessing efficacy of s-atenolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
Method for assessing efficacy of pravastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of ivabradin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessing efficacy of simvastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle